Vimarsana
Biggest News Aggregation in the World

Page 50 - Relations Manager News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Relations Manager. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Relations Manager Today - Breaking & Trending Today

Revolutionizing Ride-Hailing: inDrive Conquers 20 African Cities in 2023 with Groundbreaking Zero Commission Model - Vimarsana News

Revolutionizing Ride-Hailing: inDrive Conquers 20 African Cities in 2023 with Groundbreaking Zero Commission Model

1

Sandvik strengthens position in electrical vehicles with acquisition of software supplier esco GmbH - Vimarsana News

Sandvik strengthens position in electrical vehicles with acquisition of software supplier esco GmbH

/PRNewswire/ -- Sandvik has signed an agreement to acquire esco GmbH engineering solutions consulting, a German-based supplier of software for power skiving,...

Sandvik to acquire tungsten powder manufacturer Buffalo Tungsten - Vimarsana News

Sandvik to acquire tungsten powder manufacturer Buffalo Tungsten

/PRNewswire/ -- Sandvik has signed an agreement to acquire Buffalo Tungsten, Inc. (BTI), a leading US based manufacturer of tungsten metal powder and tungsten...

Heineken Holding N.V. reports on 2023 third-quarter - Vimarsana News

Heineken Holding N.V. reports on 2023 third-quarter

Amsterdam, 25 October 2023 – Heineken Holding N.V. (HEIO; HKHHY) publishes its third quarter 2023 trading update.     Key Quarterly Highlights     ...

Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome - Vimarsana News

Ipsen updates on E.U. Marketing Authorisation Application for odevixibat in Alagille syndrome

Positive opinion from Committee for Medicinal Products for Human Use recommending approval of Bylvay® (odevixibat) based on Phase III ASSERT clinical-trial data in Alagille syndrome (ALGS) already received in July 2023Committee for Orphan Medicinal Products confirms a negative opinion of its review recommending not to maintain the orphan designation for Bylvay in ALGSIpsen plans to submit a new Marketing Authorisation Application for the treatment of ALGS by the end of 2023 under a new brand nam

Source: yahoo.com